| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |